Metabolic status and resistin in chronic schizophrenia over a 2-year period with continuous atypical antipsychotics.
about
Amisulpride Switching in Schizophrenic Patients Who Showed Suboptimal Effect and/or Tolerability to Current Antipsychotics in a Naturalistic Setting: An Explorative Study.GLP-1 receptor agonist exenatide restores atypical antipsychotic clozapine treatment-associated glucose dysregulation and damage of pancreatic islet beta cells in mice.
P2860
Metabolic status and resistin in chronic schizophrenia over a 2-year period with continuous atypical antipsychotics.
description
2015 nî lūn-bûn
@nan
2015年の論文
@ja
2015年学术文章
@wuu
2015年学术文章
@zh-cn
2015年学术文章
@zh-hans
2015年学术文章
@zh-my
2015年学术文章
@zh-sg
2015年學術文章
@yue
2015年學術文章
@zh
2015年學術文章
@zh-hant
name
Metabolic status and resistin ...... nuous atypical antipsychotics.
@ast
Metabolic status and resistin ...... nuous atypical antipsychotics.
@en
type
label
Metabolic status and resistin ...... nuous atypical antipsychotics.
@ast
Metabolic status and resistin ...... nuous atypical antipsychotics.
@en
prefLabel
Metabolic status and resistin ...... nuous atypical antipsychotics.
@ast
Metabolic status and resistin ...... nuous atypical antipsychotics.
@en
P2093
P2860
P356
P1476
Metabolic status and resistin ...... nuous atypical antipsychotics.
@en
P2093
Haruhiko Osawa
Hiroshi Onuma
Kentaro Kawabe
Shinichiro Ochi
Shu-Ichi Ueno
Yoshiki Hosoda
Yuta Yoshino
P2860
P304
P356
10.1177/2045125315596697
P577
2015-10-01T00:00:00Z